Protective effect of daidzein on ovarian ischemia‑reperfusion injury in rats

Objective & Hypothesis:Purpose: In this study, our aim was to investigate the potential effects of strong antioxidant daidzein (DZ) on ovarian ischemia and reperfusion injury.

📊

Key Findings & Data:Materials and Methods: A total of 42 female Sprague-Dawley rats were randomly divided into seven groups.

💡

Conclusion & Impact:Conclusion: Daidzein has a strong protective role in the treatment of ovarian ischemia-reperfusion injury and can be used as a therapeutic agent.

🔬Design:Modeling & Simulation

📍Scope:Comprehensive Sample

⚙️Variables:Daidzein · ovaryum · iskemisi ve reperfüzyon hasarı

Abstract

Purpose: In this study, our aim was to investigate the potential effects of strong antioxidant daidzein (DZ) on ovarian ischemia and reperfusion injury. Materials and Methods: A total of 42 female Sprague-Dawley rats were randomly divided into seven groups. For the experimental model, the clamps were removed after 3 hours of ischemia, and blood flow was provided again. Then, reperfusion process was terminated for 3 hours. Daidzein was orally administered to animals at doses of 35 and 70 mg/kg 30 minutes before ischemia (I) and ischemia and reperfusion (I/R) procedures. Results: Severe immunoreactivity of the IL-1β, IL-6 and Caspase-3 were detected in I and I/R groups. Moderate immunoreactivity of IL-1β, IL-6 and Caspase-3 was detected in I+DZ35 and I/R+DZ35 groups, and slightly positivity was detected in I+DZ70 and I/R+DZ70 groups. The SOD activity level increased in the groups treated with Daidzein, while MDA levels decreased. In addition, hemorrhage areas and inflammatory cell migration decreased in I/R+DZ70 and I/R+DZ35 groups, when compared to I/R group in a dose dependent manner. Conclusion: Daidzein has a strong protective role in the treatment of ovarian ischemia-reperfusion injury and can be used as a therapeutic agent.

Özet

Amaç: Bu çalışmada, güçlü antioksidan daidzeinin (DZ) over iskemi ve reperfüzyon hasarı üzerindeki potansiyel etkisini araştırdık. Gereç ve Yöntem: Toplam 42 adet dişi Sprague-Dawley sıçan rastgele yedi gruba ayrıldı. Deney modeli için, 3saatlik iskeminin ardından klempler çıkarıldı ve tekrar kan akışı sağlandı. Reperfüzyon 3 saatin sonunda sonlandırıldı. Daidzein, iskemi (I) ve iskemi ve reperfüzyon (I/R) işlemlerinden 30 dakika önce hayvanlara ağızdan 35 ve 70 mg/kg dozlarında uygulandı. Bulgular: I ve I/R gruplarında IL-1β, IL 6 ve Caspase 3'ün şiddetli immünoreaktivite görüldü. I+DZ35 ve I/R+DZ35 gruplarında IL-1β, IL 6 ve Kaspaz 3'ün immünreaktivitesi orta düzeyde iken, I+DZ70 ve I/R+DZ70 gruplarında hafif pozitiftir. Daidzein ile tedavi edilen gruplarda SOD aktivite seviyesi artarken, MDA seviyeleri azaldı. Ayrıca I/R + DZ70 ve IR+DZ35 gruplarında I/R grubuna göre doza bağlı olarak kanama alanları ve inflamatuar hücre göçü azaldı. Sonuç: Daidzein, over iskemi-reperfüzyon hasarının tedavisinde güçlü bir koruyucu role sahiptir ve terapötik bir ajan olarak kullanılabilir.

Keywords

Daidzein ovaryum iskemisi ve reperfüzyon hasarı sıçan ovary ischemia‑reperfusion injury rat

🔖

Cite This Article

TOKTAY, E., GÜRBÜZ, M. A., BAL, T., ÖZGÜL, Ö., ERBAŞ, E., UGAN, R. A., SELLİ, J. (2022). Protective effect of daidzein on ovarian ischemia‑reperfusion injury in rats. Cukurova Medical Journal, Cilt: 47 - Sayı: 1, 102–110. https://ajindex.com/articles/387117

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (14)

Aslan M, Erkanli Senturk G, Akkaya H, Sahin S and Yilmaz B. The effect of oxytocin and Kisspeptin-10 in ovary and uterus of ischemia-reperfusion injured rats. Taiwan J Obstet Gynecol. 2017;56:456-62
Fazilet B, Süleyman G, Emine G, Mehtap P. Overview of ovarian torsion. Kocatepe Med J. 2016;17:30-35
Srivastava G, Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther. 2009;14:22-27
Chen M, Chen CD, Yang YS. Torsion of the previously normal uterine adnexa. Evaluation of the correlation between the pathological changes and the clinical characteristics. Acta Obstet Gynecol Scand. 2001;80:58-61
Halici Z, Karaca M, Keles ON, Borekci B, Odabasoglu F, Suleyman H et al. Protective effects of amlodipine on ischemia-reperfusion injury of rat ovary: biochemical and histopathologic evaluation. Fertility and sterility. 2008;90:2408-15
Geyikoglu F, Koc K, Erol HS, Colak S, Ayer H, Jama S et al. The propolis and boric acid can be highly suitable, alone/or as a combinatory approach on ovary ischemia-reperfusion injury. Arch Gynecol Obstet. 2019;300:1405-12
Ersoz N, Guven A, Cayci T, Uysal B, Turk E, Oztas E et al. Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS. Ren Fail. 2009;31:704-10
Kesik V, Guven A, Vurucu S, Tunc T, Uysal B, Gundogdu G et al. Melatonin and 1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion. J Surg Res. 2009;157:e97-e105
Nayki UA, Nayki C, Cetin N, Cimen FK, Coban A, Mammadov R et al. Effect of Kineret(R) on ovarian ischemia reperfusion injury in a rat model. J Obstet Gynaecol Res. 2016;42:1525-33
Oguzhan O, Huseyin E, Gokhan C, Zafer Y. Oxidative stress and its impacts on intracellular lipids, proteins and DNA. J Clin Exp Invest. 2015;6:331-36
Zhang F, Ru N, Shang ZH, Chen JF, Yan C, Li Y et al. Daidzein ameliorates spinal cord ischemia/reperfusion injury-induced neurological function deficits in Sprague-Dawley rats through PI3K/Akt signaling pathway. Exp Ther Med. 2017;14:4878-86
Rufer CE, Kulling SE. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem. 2006;54:2926-31
L'Homme R, Brouwers E, Al-Maharik N, Lapcik O, Hampl R, Mikola H et al. Time-resolved fluoroimmunoassay of plasma and urine Odesmethylangolensin. J Steroid Biochem Mol Biol. 2002;81:353-61
Choi EJ and Kim GH. The ant